Louis Picker, M.D., and his team have been awarded a $25 million grant from the Bill & Melinda Gates Foundation that will spur their work on a vaccine candidate against HIV. This work is based on previous findings that this candidate, which uses cytomegalovirus as a vector, can boost effector memory T cells to successfully target simian immunodeficiency virus. This new award will test the safety of a prototype human version of the vaccine in a phase I clinical trial in humans, as well as optimize the vaccine for phase II trials. Read the OHSU media release here, and here’s the Oregonian story.
Welcome to the Research News Blog
OHSU Research News is your portal to information about all things research at OHSU. Find updates on events, discoveries, and important funding information.
Recent Blog Posts
- Sex, cognition, and stimulating neurons: Katie Wallin-Miller featured in OHSU In the Lab
- New treatment may address imatinib-resistant tumors
- Innovation Workshop: Spring to Market, registration now open
- kheadrick on NIMH new innovator award recognizes leader in autism research
- Jane Kim-Hoffman on Michael Chiang recognized for contributions to medical informatics
- Katie Jones on Xiaolu “Lulu” Cambronne awarded an NIH New Innovator Award
Awards Basic research Brown bag Cancer Career development Clinical research Collaboration Community Conference Cores Discoveries eIRB Event events Funding Funding focus Funding opportunity funding opportunity Graduate students Internal funding IRB notes Junior faculty Lecture Limited submission Neuroscience NIH NIH News OCTRI OHSU faculty OHSU Knight Cancer Institute OHSU researchers ONPRC Postdoctoral fellows Research Research administration Research integrity Research resources Research week Seminar Technology Training Translational research TTBD Visiting speaker Workshop